When appropriate, the use of appetite suppressants or other medications may be incorporated into the weight loss plan for a patient. Some of the medications that may be considered for patients include:
Saxenda is a medication approved by the FDA in December of 2014 for the treatment of obesity in conjunction with a comprehensive weight management program. A glucagon-like-peptide-1 (GLP-1) agonist, it is an injectable medication similar to Victoza which is approved for the treatment of diabetes. It has shown promise as a weight loss medication since its approval in December 2014, especially in combination with a program such as Salveo Weight Management. Saxenda works by enhancing satiety (feeling of fullness) and reduction of portion size/calories. Saxenda is not appropriate for all patients, so the physicians will discuss all options with you.
Contrave is an FDA approved medication that combines naltrexone and bupropion. Both of these medications have been available for years. Naltrexone is designed to treat addictive behaviors and bupropion has been used to treat depression and tobacco addiction. Combined, these medications have had great success in assisting patients lose weight in combination with a comprehensive weight management program. The physicians will be happy to work with you to decide what is best for your weight loss needs.
Phentermine was first approved by the Food and Drug Administration in 1959 as a short term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction. The most common and most extensively used medications in this category are phentermine, phendimetrazine and diethylpropion. The Obesity Medicine Association (OMA) and other obesity organizations have reviewed the medical literature and believe that, under physician supervision, the extended use of these medications is safe. Salvéo physicians will screen for any medical conditions that would make their use unsafe. OMA physicians also understand that medication use alone is not sufficient for the safe and long term maintenance of weight loss. Therefore, Salvéo only prescribes these medications when medically appropriate, under close medical supervision and when combined with our comprehensive weight management program.
Qsymia is a medication used for weight loss. In clinical trials, Qsymia was associated with modest but statistically significant weight loss when compared with placebo. This weight loss was associated with improvements in weight-related comorbidities such as improved glycemia, decreased blood pressure, and improved cholesterol. Qsymia is a combination of two medications that have been available for years. Topamax is an antiseizure medication and phentermine is an appetite suppressant. Every medical treatment for weight loss must be accompanied by a comprehensive program. You can discuss with the Salvéo physicians if this medicine might be right for you.
Belviq is a medication that works centrally (in the brain) to help with satiety (feeling full). This leads to reduced food consumption and weight loss. The exact mechanism of action is not known. We have read the research and are following the ongoing studies regarding this medication. Every medical treatment for weight loss must be accompanied by a comprehensive program. Please ask the Salvéo physicians if this medicine might be right for you.